No Data
No Data
Haisco Pharmaceutical Group (002653.SZ) proposes a profit distribution plan for the first three quarters of 2024: a distribution of 1.35 yuan for every 10 shares.
On December 30, Gelonghui reported that Haisco Pharmaceutical Group (002653.SZ) announced the profit distribution plan for the first three quarters of 2024: it intends to distribute a cash dividend of 1.35 yuan (including tax) for every 10 shares based on the existing total share capital of 1,119,917,970 shares, totaling a cash dividend of 0.151 billion yuan.
Express News | Haisco Pharmaceutical Group: Innovative Drug HSK 0.0445 million tablets have two new indications accepted.
Express News | Institutions are bullish on these stocks today.
Haisco Pharmaceutical Group (002653): The research and development pipeline is continuously advancing, and the results of the innovative transformation are significant.
The R&D pipeline continues to advance, and the results of the innovative transformation are significant. The company started with specialty generic drugs and has now transformed into an innovative pharmaceutical enterprise in the fields of anesthesia and analgesia, diabetes and complications, tumors, neuropathic pain, and more. Currently, there are more than 40 varieties that are the first or exclusive in the country.
Express News | Haisco Pharmaceutical Group: The changes in shareholding of the controlling shareholder and its concerted action parties have reached 1%.
Express News | haisco pharmaceutical group: HSK46575 tablets approved for clinical trials.